Attached files
file | filename |
---|---|
10-Q/A - NORTHWEST BIOTHERAPEUTICS INC | v208903_10qa.htm |
EX-31.1 - NORTHWEST BIOTHERAPEUTICS INC | v208903_ex31-1.htm |
EXHIBIT
32.1
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the quarterly report of Northwest Biotherapeutics, Inc. (the
“Company”) on Form 10-Q for the period ended September 30, 2010, as filed with
the Securities and Exchange Commission (the “Report”), I, Alton L. Boynton,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:
(1)
|
The
Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
Date:
January 17, 2011
|
/s/
ALTON L. BOYNTON
|
Alton
L. Boynton
|
|
President
and Chief Executive Officer
|
|
(principal
executive officer and principal accounting
officer)
|